https://orcid.org/0000-0002-4831-1866
References
- Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi:10.1056/NEJMoa2001316
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi:10.1056/NEJMoa2001017
- World Health Organisation. Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committe Regarding the Outbreak of Novel Coronavirus (2019-nCoV); 2020. Available from:https://www.who.int/news/item/01-08-2020-statement-on-the-fourth-meeting-of-the-interNational-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-coronavirus-disease-(covid-19). Accessed August 1, 2020.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi:10.1056/NEJMoa2002032
- Pourrajab F, Zare-Khormizi MR, Sheikhha MH. Molecular basis for pathogenicity of human coronaviruses. Infect Drug Resist. 2020;13:2385–2405. doi:10.2147/IDR.S255156
- Sabino EC, Buss LF, Carvalho MPS, et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet. 2021;397:452–455. doi:10.1016/S0140-6736(21)00183-5
- Munoz M, Patino LH, Ballesteros N, Paniz-Mondolfi A, Ramirez JD. Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages? Int J Infect Dis. 2021;105:329–332. doi:10.1016/j.ijid.2021.02.073
- Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372. doi:10.1126/science.abg3055
- Kruttgen A, Cornelissen CG, Dreher M, Hornef MW, Imohl M, Kleines M. Comparison of the SARS-CoV-2 rapid antigen test to the real star Sars-CoV-2 RT PCR kit. J Virol Methods. 2020;288:114024. doi:10.1016/j.jviromet.2020.114024
- Nalla AK, Casto AM, Huang MW, et al. Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. J Clin Microbiol. 2020;58. doi:10.1128/JCM.00557-20
- Green DA, Zucker J, Westblade LF, et al. Clinical performance of SARS-CoV-2 molecular tests. J Clin Microbiol. 2020;58. doi:10.1128/JCM.00995-20
- Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25. doi:10.2807/1560-7917.ES.2020.25.3.2000045
- Centers for disease control and prevention. 2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes; 2020. Available from:https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-primer-probes.pdf. Accessed May 29, 2020.
- Wollschlager P, Todt D, Gerlitz N, et al. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay. Clin Microbiol Infect. 2021;27:1353.e1–1353.e5. doi:10.1016/j.cmi.2021.05.025
- Penarrubia L, Ruiz M, Porco R, et al. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak. Int J Infect Dis. 2020;97:225–229. doi:10.1016/j.ijid.2020.06.027
- Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020;58:1070–1076. doi:10.1515/cclm-2020-0285
- Jian MJ, Chung HY, Chang CK, et al. Clinical comparison of three sample-to-answer systems for detecting SARS-CoV-2 in B.1.1.7 lineage emergence. Infect Drug Resist. 2021;14:3255–3261. doi:10.2147/IDR.S328327
- Jian MJ, Chung HY, Chang CK, et al. Novel automated sample-to-result SARS-CoV-2 laboratory-developed RT-PCR assay for high-throughput testing using LabTurbo AIO 48 system. Clin Chim Acta. 2020;514:54–58. doi:10.1016/j.cca.2020.12.003
- World Health Organization. Coronavirus disease (COVID-19) epidemiological update; 2021. Available from: https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19—25-october-2021. Accessed October 25, 2021.
- Neopane P, Nypaver J, Shrestha R, Beqaj SS. SARS-CoV-2 variants detection using TaqMan SARS-CoV-2 mutation panel molecular genotyping assays. Infect Drug Resist. 2021;14:4471–4479. doi:10.2147/IDR.S335583
- Chu DKW, Pan Y, Cheng SMS, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020;66:549–555. doi:10.1093/clinchem/hvaa029